Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 CAD | +1.37% | -1.33% | -26.00% |
03-28 | Rubicon Organics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-28 | Transcript : Rubicon Organics Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.00% | 14.91M | - | ||
+40.74% | 284M | - | ||
+32.99% | 270M | - | ||
+50.58% | 198M | C | ||
-31.64% | 146M | C | ||
+56.59% | 142M | - | ||
+147.89% | 140M | - | - | |
-14.29% | 120M | - | - | |
-7.69% | 89.69M | - | - | |
+150.00% | 75.33M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- ROMJ Stock
- Ratings Rubicon Organics Inc.